There are 3162 resources available
Invited Discussant LBA38 and LBA39
Presenter: Maeve Lowery
Session: Proffered paper session 1: GI tumours, upper digestive
Resources:
Slides
Webcast
Should we be screening in never smokers for NSCLC?
Presenter: Pan-Chyr Yang
Session: Lung cancer interception: New approaches to lung cancer screening and prevention
Resources:
Slides
Webcast
Invited Discussant 988O and 989O
Presenter: Kevin Harrington
Session: Proffered paper session: Investigational immunotherapy
Resources:
Slides
Webcast
Invited Discussant 603O and 612O
Presenter: Christophe Le Tourneau
Session: Proffered paper session 1: Developmental therapeutics
Resources:
Slides
Webcast
Fertility preservation and beyond in male patients with cancer
Presenter: Christine Wyns
Session: Oncofertility: What every HCP involved in cancer care should know
Resources:
Slides
Webcast
Integrated Cancer Prevention Center: One Stop Shop
Presenter: Nadir Arber
Session: The dark age of single cancer screening is over
Resources:
Slides
Webcast
Time toxicity of cancer treatment
Presenter: Raffaele Giusti
Session: 9th ESMO Designated Centres of Integrated Oncology and Palliative Care session and awards: Specific considerations for integration of oncology and palliative care
Resources:
Slides
Webcast
VP1-2024: RATIONALE-315: Event-free survival (EFS) and overall survival (OS) of neoadjuvant tislelizumab (TIS) plus chemotherapy (CT) with adjuvant TIS in resectable non-small cell lung cancer (NSCLC)
Presenter: Dongsheng Yue
Session: ESMO Virtual Plenary revisited
Resources:
Slides
Webcast
1721MO - Safety and efficacy of olutasidenib, an IDH1 mutant inhibitor, for the treatment of recurrent/relapsed or locally advanced or metastatic IDH1 mutated chondrosarcoma
Presenter: Florence Duffaud
Session: Mini oral session: Sarcoma
Resources:
Abstract
Slides
Webcast
Invited Discussant 1925MO and 1926MO
Presenter: Sophie Leboulleux
Session: Mini oral session: NETs and endocrine tumours
Resources:
Slides
Webcast